Cardio Diagnostics Holdings: Revolutionizing Cardiovascular Disease Prevention and Detection with AI-Powered Precision Medicine

miércoles, 1 de abril de 2026, 3:37 pm ET1 min de lectura
CDIO--

Cardio Diagnostics Holdings (CDIO) is a precision cardiovascular medicine company that uses artificial intelligence and biomarkers to detect and manage cardiovascular disease. The company's non-invasive, blood-based tests can identify coronary heart disease that traditional methods may miss. CDIO has established multiple commercialization channels and recently expanded into India and secured CMS reimbursement rates.

Cardio Diagnostics Holdings: Revolutionizing Cardiovascular Disease Prevention and Detection with AI-Powered Precision Medicine

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios